Brief: Group Of Shareholders Of Sernova Corporation - Regarding Management Compensation, Increases Recommended By Sernova Corp Are "Unreasonable"
17/04/2023 13:15
April 17 (Reuters) - Sernova Corp SVA.TO :
* GROUP OF SHAREHOLDERS OF SERNOVA CORPORATION - REGARDING
MANAGEMENT COMPENSATION, INCREASES RECOMMENDED BY SERNOVA CORP
ARE "UNREASONABLE"
* GROUP OF SHAREHOLDERS OF SERNOVA CORPORATION - URGE ALL
SERNOVA
CORP SHAREHOLDERS TO VOTE ACCORDING TO GOLD PROXY
Source text for Eikon: ID:nCNWfrC1Ca
Further company coverage: SVA.TO
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints